# Walter Reinisch

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/walter-reinisch-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,157 |
| Field | Inflammatory Bowel Disease |
| h-index | 44 |
| i10-index | 62 |
| Last Known Institution | Pädagogische Hochschule Wien |
| OpenAlex ID | https://openalex.org/A5109181583 |
| Works | 133 |

## Researcher papers

- [Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target](https://scholariq.org/papers/selecting-therapeutic-targets-in-inflammatory-bowel-disease-stride-determining/)
- [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management](https://scholariq.org/papers/second-european-evidence-based-consensus-on-the-diagnosis-and-management-of/)
- [Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial](https://scholariq.org/papers/secukinumab-a-human-anti-il-17a-monoclonal-antibody-for-moderate-to-severe-crohn/)
- [Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines](https://scholariq.org/papers/imaging-techniques-for-assessment-of-inflammatory-bowel-disease-joint-ecco-and/)
- [Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn’s Disease](https://scholariq.org/papers/long-term-efficacy-and-safety-of-stem-cell-therapy-cx601-for-complex-perianal/)
- [Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection](https://scholariq.org/papers/infliximab-reduces-endoscopic-but-not-clinical-recurrence-of-crohn-s-disease/)
- [Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED–ECCO consensus](https://scholariq.org/papers/role-of-small-bowel-endoscopy-in-the-management-of-patients-with-inflammatory/)
- [Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease](https://scholariq.org/papers/deep-remission-at-1-year-prevents-progression-of-early-crohn-s-disease/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)

## Researcher university

- [Pädagogische Hochschule Wien](https://scholariq.org/institutions/padagogische-hochschule-wien/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.